Law360, New York (October 25, 2004, 12:00 AM ET) -- A unit of drug maker Bayer Group has agreed to take a license for a technology covering homocysteine assays, following Competitive Technologies’ victory in its five-year patent infringement lawsuit against LabCorp over the same technology.
Under the accord reached, Bayer was granted a license under the Competitive Technologies patent and will pay royalties on sales of Bayer homocysteine assays, the companies said in a joint release.
Customers who purchase Bayer homocysteine assays will be covered by the Bayer license from Competitive Technologies. Bayer customers such as...
Bayer Takes License For Homocysteine Assay
To view the full article, take a free trial now.
